1. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11);Mathijssen;Clin. Cancer Res.,2001
2. Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer;Yoshimatsu;Anticancer Res.,2007
3. Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer;Oostendorp;Anti-Cancer Drugs,2010
4. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions;Slatter;Drug Metab. Dispos.,1997
5. Clinical pharmacokinetics of irinotecan;Chabot;Clin. Pharmacokinet.,1997